FOXO Profile
FOXO Technologies Inc. is a forward-thinking technology platform company dedicated to advancing longevity science and integrating it into the life insurance sector. The company specializes in developing innovative products and services that merge scientific research on aging with life insurance processes to enhance the underwriting journey and foster consumer health and wellness engagement.
FOXO Technologies offers cutting-edge solutions such as FOXO Labs, an advanced epigenetic biomarker technology that utilizes saliva samples to provide comprehensive assessments of underwriting factors. This technology enables life insurers to evaluate risk more accurately and efficiently, streamlining the underwriting process while delivering valuable insights into an individual's biological age and health status.
In addition to its biomarker technology, FOXO Technologies provides FOXO Life, a comprehensive sales and distribution platform aimed at empowering independent life insurance agents. FOXO Life leverages the Longevity Report, a unique product that incorporates longevity science into life insurance offerings, thereby assisting agents in delivering more personalized and relevant insurance solutions to clients. This platform is designed to support the recruitment and management of agents, enhancing their ability to sell life insurance products effectively.
Founded in 2020 and headquartered in Minneapolis, Minnesota, FOXO Technologies Inc. operates as a subsidiary of FOXO Management LLC. The company's commitment to merging longevity science with life insurance represents a significant innovation in the industry, offering new tools and approaches to improve both the underwriting process and overall consumer engagement in health and wellness
|
